<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou X</submitter><funding>Fundamental Research Funds for the Central Universities</funding><funding>National Natural Science Foundation of China</funding><funding>Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><pagination>e2308077</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11040334</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(16)</volume><pubmed_abstract>The foreign body response (FBR) to implanted biomaterials and biomedical devices can severely impede their functionality and even lead to failure. The discovery of effective anti-FBR materials remains a formidable challenge. Inspire by the enrichment of glutamic acid (E) and lysine (K) residues on human protein surfaces, a class of zwitterionic polypeptide (ZIP) hydrogels with alternating E and K sequences to mitigate the FBR is prepared. When subcutaneously implanted, the ZIP hydrogels caused minimal inflammation after 2 weeks and no obvious collagen capsulation after 6 months in mice. Importantly, these hydrogels effectively resisted the FBR in non-human primate models for at least 2 months. In addition, the enzymatic degradability of the gel can be controlled by adjusting the crosslinki</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>Poly(Glutamic Acid-Lysine) Hydrogels with Alternating Sequence Resist the Foreign Body Response in Rodents and Non-Human Primates.</pubmed_title><pmcid>PMC11040334</pmcid><funding_grant_id>22175152</funding_grant_id><funding_grant_id>226-2022-00146</funding_grant_id><funding_grant_id>52103188</funding_grant_id><funding_grant_id>2022YFB3807300</funding_grant_id><funding_grant_id>LHDMZ22H300011</funding_grant_id><funding_grant_id>226‐2022‐00146</funding_grant_id><pubmed_authors>Yao K</pubmed_authors><pubmed_authors>Zhu Z</pubmed_authors><pubmed_authors>Lu Z</pubmed_authors><pubmed_authors>Wei X</pubmed_authors><pubmed_authors>Ji J</pubmed_authors><pubmed_authors>Jia F</pubmed_authors><pubmed_authors>Ye Y</pubmed_authors><pubmed_authors>Zhou X</pubmed_authors><pubmed_authors>Liu W</pubmed_authors><pubmed_authors>Zhang P</pubmed_authors><pubmed_authors>Ni Y</pubmed_authors><pubmed_authors>Liu Z</pubmed_authors><pubmed_authors>Cao W</pubmed_authors><pubmed_authors>Han H</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Chen S</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Poly(Glutamic Acid-Lysine) Hydrogels with Alternating Sequence Resist the Foreign Body Response in Rodents and Non-Human Primates.</name><description>The foreign body response (FBR) to implanted biomaterials and biomedical devices can severely impede their functionality and even lead to failure. The discovery of effective anti-FBR materials remains a formidable challenge. Inspire by the enrichment of glutamic acid (E) and lysine (K) residues on human protein surfaces, a class of zwitterionic polypeptide (ZIP) hydrogels with alternating E and K sequences to mitigate the FBR is prepared. When subcutaneously implanted, the ZIP hydrogels caused minimal inflammation after 2 weeks and no obvious collagen capsulation after 6 months in mice. Importantly, these hydrogels effectively resisted the FBR in non-human primate models for at least 2 months. In addition, the enzymatic degradability of the gel can be controlled by adjusting the crosslinki</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Apr</publication><modification>2025-04-22T20:43:55.757Z</modification><creation>2025-04-06T03:18:00.145Z</creation></dates><accession>S-EPMC11040334</accession><cross_references><pubmed>38403462</pubmed><doi>10.1002/advs.202308077</doi></cross_references></HashMap>